...
首页> 外文期刊>Breast care >Alleviation of brain edema and restoration of functional independence by bevacizumab in brain-metastatic breast cancer: A case report
【24h】

Alleviation of brain edema and restoration of functional independence by bevacizumab in brain-metastatic breast cancer: A case report

机译:贝伐单抗在脑转移性乳腺癌中减轻脑水肿和恢复功能独立性的一例报告

获取原文
获取原文并翻译 | 示例

摘要

Background: Brain metastases (BM) are an increasing challenge in modern oncology, as treatment options especially after exhaustion of local treatment approaches are very limited. Patient and Methods: A long-term surviving patient with brain-only metastatic breast cancer, who presented at our department with massive corticosteroid-refractory brain edema with serious neurological symptoms after exhaustion of all local therapy options, was started on bevacizumab. Results: Initiation of bevacizumab monotherapy led to rapid decrease of contrast-enhancing lesions and alleviation of brain edema, and allowed tapering and termination of corticosteroid administration. Neurological and neurocognitive function was restored and marked improvement in quality of life was observed. Conclusion: Our case highlights that bevacizumab may represent a feasible and effective salvage treatment option in selected patients with BM.
机译:背景:脑转移(BM)在现代肿瘤学中是一个日益严峻的挑战,因为治疗选择尤其是在用尽局部治疗方法后非常有限。患者和方法:使用贝伐单抗开始治疗一名长期存活的仅脑转移性乳腺癌患者,该患者在用完所有局部疗法后在我科出现大量皮质类固醇难治性脑水肿,并伴有严重的神经系统症状。结果:开始使用贝伐单抗单药治疗可迅速减少增强造影剂的病灶,减轻脑水肿,并逐渐减少和终止皮质类固醇激素的给药。神经和神经认知功能得以恢复,生活质量得到显着改善。结论:我们的病例表明,贝伐单抗在某些BM患者中可能是一种可行且有效的挽救治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号